| Thu, Jul 9, 2009 | | • | UPDATE - Amylin obesity product positive in mid-stage study
at Reuters (Thu 8:17am)
| | • | Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity
PR Newswire (Thu 7:45am)
| | Wed, Jul 8, 2009 | | • | Wall Street rallies in choppy trade
at FT.com (Wed, Jul 8)
| | • | You Ask, Rothbort Answers
at TheStreet.com (Wed, Jul 8)
| | • | Movers roundup: Family Dollar, Steak n Shake
AP (Wed, Jul 8)
| | • | Wall St awaits second quarter earnings
at FT.com (Wed, Jul 8)
| | • | Amylin shares rise as FDA reviews diabetes drug
AP (Wed, Jul 8)
| | • | FDA will review Amylins exenatide application
at bizjournals.com (Wed, Jul 8)
| | Tue, Jul 7, 2009 | | • | Stocks to Watch: Stocks in focus for Wednesday
at MarketWatch (Tue, Jul 7)
| | • | FDA accepts application for weekly diabetes drug
AP (Tue, Jul 7)
| | • | AMYLIN PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Jul 7)
| | • | New Drug Application for Exenatide Once Weekly Accepted for Review by FDA
PR Newswire (Tue, Jul 7)
| | Fri, Jul 3, 2009 | | • | UPDATE - Novo Nordisk says Victoza cleared for EU market
at Reuters (Fri, Jul 3)
| | Wed, Jul 1, 2009 | | • | 3 Stocks Ready to Roar
at Motley Fool (Wed, Jul 1)
| | Tue, Jun 30, 2009 | | • | One-Drug Wonders Deserve a Spot in Your Portfolio
at Motley Fool (Tue, Jun 30)
| | Mon, Jun 29, 2009 | | • | Lantus Results: Reply Hazy, Try Again Later
at Motley Fool (Mon, Jun 29)
| | Fri, Jun 26, 2009 | | • | Friday's Options Recap
at Seeking Alpha (Fri, Jun 26)
| | • | Rumors and Safety Issues -- One Bad Combination
at Motley Fool (Fri, Jun 26)
| | • | Looking for a Sliver of the Me-Too Pie
at Motley Fool (Fri, Jun 26)
| | • | A Sanofi Safety Scare?
at CNBC (Fri, Jun 26)
|
Add AMLN News to My Yahoo!:
 
| |
|
0.06% Nasdaq 0.00%
Headlines
